Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders
The instant invention provides methods and compositions for the treatment and prevention of Marfan syndrome and related diseases, disorders and conditions. The invention further provides pharmaceutical compositions and kits for the treatment and prevention of Marfan syndrome and related diseases, disorders and conditions.
1. A method of treating a subject having a Marfan-associated condition selected from the group consisting of aneurysm, an aortic aneurysm, emphysema, valve disease, hypotonia, and myopathy comprising:
administering to the subject post-natally an effective amount of an antibody or antibody fragment selected from the group consisting of an F(ab) fragment, F(ab) 2 fragment, Fv fragment, or a single chain antibody that binds and neutralizes TGFβ; thereby treating the subject.